Side-by-side comparison of AI visibility scores, market position, and capabilities
GenAI-native sales performance management platform for ICM, territory planning, and quota management. Named the only SPM vendor with in-depth AI in Q1 2025 Forrester Wave.
Varicent is a sales performance management (SPM) software company headquartered in Toronto, Canada, offering a GenAI-native platform that aligns sales strategy, compensation execution, and performance tracking in a single system. Varicent's product portfolio spans incentive compensation management (ICM), territory management, quota planning, and channel management—enabling organizations to design, calculate, and govern complex commission plans at enterprise scale.\n\nA key differentiator is Varicent's AI foundation: the company was named the only solution evaluated with an in-depth set of AI capabilities in the Q1 2025 Forrester Wave for Sales Performance Management Solutions for Incentive Compensation, earning a Leader designation. The platform's GenAI features assist compensation administrators with plan modeling, anomaly detection in commission calculations, and natural-language queries against compensation data—reducing the manual effort required to manage large-scale SPM deployments.\n\nVaricent serves global enterprise clients across financial services, technology, manufacturing, and insurance, with particular strength in financial services firms managing broker-dealer and advisor compensation. The company's orchestration model connects strategy (goal setting, territory design), performance (pipeline data, attainment tracking), and execution (commission calculations, payout processing), enabling revenue leaders to see the full picture in one place. Varicent competes with Xactly, Anaplan, CaptivateIQ, and SAP for enterprise SPM market share.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.